[{"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "62530", "recalling_firm": "Noven Pharmaceuticals, Inc.", "address_1": "11960 Sw 144th St", "address_2": "N/A", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico.", "recall_number": "D-1653-2012", "product_description": "Daytrana (methylphenidate) transdermal system patch, Delivers 20 mg over 9 hours (2.2 mg/hr), 1 patch per pouch, packaged in 30-count patches per box, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, By Noven Pharmaceuticals, Inc., Miami, FL 33186; NDC 68968-5554-3.", "product_quantity": "177,900 patches", "reason_for_recall": "Miscalibrated and/or Defective Delivery System: Out of Specification results for mechanical peel force and/or the z-statistic value which relates to the patient's ability to remove the release liner from the patch adhesive prior to administration.", "recall_initiation_date": "20120712", "center_classification_date": "20120817", "termination_date": "20140804", "report_date": "20120829", "code_info": "Lot # 55302, Exp 12/12"}, {"status": "Terminated", "city": "Rochester", "state": "MI", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA018261"], "brand_name": ["PITOCIN"], "generic_name": ["OXYTOCIN"], "manufacturer_name": ["Endo USA, Inc."], "product_ndc": ["42023-116"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["OXYTOCIN"], "rxcui": ["207315", "238013", "1791721", "1791723"], "spl_id": ["e00f2acb-4c77-41a3-ae91-61f8356233ef"], "spl_set_id": ["969d5b35-0add-4c23-9605-6a5b6ab65c95"], "package_ndc": ["42023-116-25", "42023-116-01", "42023-116-02"], "is_original_packager": [true], "nui": ["N0000009705", "N0000175828", "M0015703"], "pharm_class_pe": ["Increased Uterine Smooth Muscle Contraction or Tone [PE]"], "pharm_class_epc": ["Oxytocic [EPC]"], "pharm_class_cs": ["Oxytocin [CS]"], "unii": ["1JQS135EYN"]}, "product_type": "Drugs", "event_id": "62013", "recalling_firm": "JHP Pharmaceuticals, LLC", "address_1": "870 Parkdale Rd", "address_2": "", "postal_code": "48307-1740", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1420-2012", "product_description": "Pitocin (Oxytocin Injection, USP) Synthetic 10 units per mL 10 mL, Rx only, Manufactured and Distributed by: JHP Pharmaceuticals, LLC Rochester, MI 48307 NDC 42023-116-02", "product_quantity": "26100 vials", "reason_for_recall": "Labeling: Label Mix-up: Pitocin storage conditions should be labeled, \"Store between 20\u00bf to 25\u00bfC (68\u00bf to 77\u00bfF)\". Pitocin lot 225867 and part of Pitocin lot 231423 were labeled, \"Store between 20\u00bf to 25\u00bfC (28\u00bf to 77\u00bfF)\".", "recall_initiation_date": "20120605", "center_classification_date": "20120716", "termination_date": "20121105", "report_date": "20120725", "code_info": "Lot  231423, 255867", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "7 units", "code_info": "Rx #'s:  0383652    0383653    0383653    0383652    0383652    0383651    0383651", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "BUPIVACAINE/LIDOCAINE/METHYLPREDNISOLONE 0.17% / 0.67% / 2.7% INJECTABLE 15 ML, 18.75 ML, 26.25 ML, 37.5 ML, 45 ML; BUPIVACAINE/LIDOCAINE/METHYLPREDNISOLONE 0.22% / 0.88% / 0.88% INJECTABLE 450 ML, 900 ML (7 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1477-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:  0387441", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "CYCLOPENTALATE/PHENYLEPHRINE  1%/2.5% OPHTHALMIC 5 ML (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1493-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:N0408712", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "BUPIVACAINE/CLONIDINE/MORPHINE/ZICONOTIDE, P.F. 20MG/400MCG/20MG/1.5MCG/ML INTRA 20 ML (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1473-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "202 units", "code_info": "Rx #'s:  0387858        0387858    0387858    0360970    0360970    0360970    0360970    0394556    0394868    0388495    0389506    0401222    0406557    0393109          0390858    0406557    0394195    0384679    0390858        0401222    0386372    0393109    0387476    0387651      0394195    0396927    0400464    0384679    0389105        0389105    0389105    0387476      0384679    0388495    0389105      0387476    0392323    0393109    0394195    0390858    0389105    0391704    0391704        0391704      0365030    0392325    0359065    0364511    0365182      0366253      0366265    0370058    0384847    0387893        0387894    0388887      0392782    0393234          0393654        0395364    0400787    0401230    0408490    0394164    0350907    0354075      0364511            0370058      0384847    0387894    0388887    0392782        0393234    0394910      0395364        0410310    0394449    0388820    0354075    0364600      0370665        0393234    0393654    0394164    0395364    0400787    0370665      0349864    0384847    0403576    0370058    0366253      0388820    0370058    0370058    0373554    0370665    0393234    0359065    0366368    0373554    0384847    0387893    0387894    0388887      0393915      0394164      0390169      0394074    0394164    0400289      0389633      0394449    0394557    0388093    0382934    0379184    0379184          0388093            0394557      0388093    0390228    0390228    0390228    0390228    0390228    0403847    0403851    0387650      0396924    0358285      0376244    0397588      0404422      0404430      0376244    0376244    0376244    0376244    0376244    0376244    0376244", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "FLUORESCEIN/INDOCYANINE, LYOPHILIZED 200MG/10MG VIAL INJECTABLE 12 VIAL, 20 VIAL, 24 VIAL; FLUORESCEIN/INDOCYANINE, LYOPHILIZED 200MG/15MG VIAL INJECTABLE 23 VIAL, 25 VIAL, 30 VIAL, 7 VIAL; FLUORESCEIN/INDOCYANINE, LYOPHILIZED 200MG/5MG VIAL INJECTABLE 1 VIAL, 10 VIAL, 12 VIAL, 13 VIAL, 15 VIAL, 2 VIAL, 20 VIAL, 24 VIAL, 3 VIAL, 30 VIAL, 40 VIAL, 41 VIAL, 5 VIAL, 50 VIAL, 6 VIAL, 7 VIAL, 9 VIAL;  FLUORESCEIN/INDOCYANINE, LYOPHILIZED 300MG/5MG VIAL INJECTABLE 10 VIAL, 15 VIAL, 20 VIAL; FLUORESCEIN/INDOCYANINE, LYOPHILIZED 300MG/7.5MG VIAL INJECTABLE 20 vials, 6 VIAL; FLUORESCEIN/INDOCYANINE, LYOPHILIZED 400MG/15MG VIAL INJECTABLE 10 VIAL, 14 VIAL, 15 VIAL, 16 VIAL, 2 VIAL, 20 VIAL, 21 VIAL, 25 VIAL, 250 VIAL, 3 VIAL, 30 VIAL, 32 VIAL, 4 VIAL,\t 40 VIAL, 5 VIAL, 50 VIAL, 6 VIAL,  8 VIALS, 9 VIAL; FLUORESCEIN/INDOCYANINE, LYOPHILIZED 500MG/25MG VIAL INJECTABLE 1 VIAL, 12 VIAL, \t2 VIAL, 23 VIAL, 30 VIAL, 6 VIAL, 8 VIAL;  FLUORESCEIN/INDOCYANINE, LYOPHILIZED 600MG/12.5MG VIAL INJECTABLE 58 VIAL, 680 VIAL, 692 VIAL, 724 VIAL, 750 VIAL;  FLUORESCEIN/INDOCYANINE, LYOPHILIZED 600MG/15MG VIAL INJECTABLE 2 VIAL, 3 VIAL; FLUORESCEIN/INDOCYANINE, LYOPHYLIZED 1000MG/10MG INJECTABLE 100 VIAL, 137 VIAL, 140 VIAL,\t153 VIAL, 200 VIAL,  47 VIAL, 60 VIAL, 63 VIAL (70 DIFFEENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1519-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "224 units", "code_info": "Rx #'s:   0389516    0354047    0389060    0389207      0405939    0402042    0400827    0398001    0398001    0400827    0403914    0369558    0398001    0398001    0382651                                0398001    0401260    0401260    0388232    0391059      0392294    0405026    0383386      0396250      0398226    0400971    0409026    0388709    0388791    0393212      0393212    0388791    0392126    0354819    0355230    0363386    0363473    0364197    0368230      0368499      0368573    0368881    0375045    0379341    0379553        0383464    0387849      0389351      0389391    0390955      0392188    0394445    0394681    0394937    0395427    0395954      0396732    0397082    0404021      0404798    0405706    0406017    0408990    0409845    0365234    0393460    0359175    0348859    0351904    0356879    0363386    0364197    0364237    0365742    0366033      0366278    0374625      0375045      0376068      0376172    0380555      0383380    0384293    0387373    0387484    0388897    0392019    0392074      0392237    0394445    0395775    0395954    0397082      0399965    0399990    0403522    0404021    0405332    0407337    0384730    0387512    0389305      0396300      0353129    0355934    0362691        0363386    0363664    0364588    0368573      0368881      0371798      0375690    0376829      0380347    0383380    0387484    0388897    0392019    0392331    0392542    0392778    0394517    0395954    0395388    0355439    0358613    0362691    0366278    0375410    0375512    0375513    0375516    0375517    0375520    0375690    0384293      0387482    0392331    0408623    0376092    0399725    0354424    0392778    0405107    0408480    0408826    0373371      0375355        0375502      0375505      0375508    0375509      0375512    0375513    0375516    0375517    0375520    0392019    0392331    0395775    0398876    0368828    0392019    0358047    0387426    0391713    0393523    0404318    0391713    0391703    0402014      0391703", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "VANCOMYCIN (INTRAOCULAR) OPHTHALMIC, P.F. (BSS) 0.4% (4MG/ML) (0.4MG/0.1ML) INJE\t400 ML;  VANCOMYCIN (INTRAOCULAR) OPHTHALMIC, P.F. 1MG/0.1ML (10MG/ML) INJECTABLE\t0.1 ML  \t  \t  \t  \t  \t0.2 ML  \t1 ML  \t100 ML  \t150 ML  \t2 ML  \t  \t2 MLS  \t5 ML  \t50 ML  \t6 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t95 ML;  VANCOMYCIN HCL, FTV** 1GM INJECTABLE\t3 VIAL  \t4 VIAL;  VANCOMYCIN, FORTIFIED 1% (10MG/ML) OPHTHALMIC\t10 ML;  \t  \t  \t  VANCOMYCIN, FORTIFIED 1.5% (15MG/ML) OPHTHALMIC\t15 ML;  VANCOMYCIN, FORTIFIED 2% (20MG/ML) OPHTHALMIC\t10 ML  \t  \t  \t  \t15 ML;  VANCOMYCIN, FORTIFIED 2.5% (25MG/ML) OPHTHALMIC\t10 ML  \t  \t15 ML;  VANCOMYCIN, FORTIFIED 5% (50MG/ML) OPHTHALMIC\t10 ML  \t  \t  \t15 ML  \t5 ML;  \t  VANCOMYCIN, LYOPHILIZED, OPHTHALMIC KIT 1% KIT\t1 KIT  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t1 VIAL  \t  \t14 KIT  \t2 KIT  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t2 KITS  \t20 KIT  \t  \t  \t  \t  \t3 KIT  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t3 KITS  \t4 KIT  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t4 KITS  \t4 VIALS  \t5 KIT  \t  \t  \t  \t  \t6 KIT  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t6 VIAL  \t9 KIT;  VANCOMYCIN, SDPF - (0.2ML SYRINGE, 30G, 1/2\") 1% INJECTABLE\t0.4 ML  \t  \t0.6 ML  \t0.8 ML  \t  \t1 ML  \t1.2 ML  \t  \t  \t1.6 ML  (44 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1638-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "3 units", "code_info": "Rx #'s:   0358393    0400281", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "CYCLOPENT/KETOROLAC/PHENYLEPH/TROPICAMIDE 1%/0.5%/2.5%/1% OPHTHALMIC 70 ML (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1490-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Corona", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA072204"], "brand_name": ["LOXAPINE"], "generic_name": ["LOXAPINE"], "manufacturer_name": ["Actavis Pharma, Inc."], "product_ndc": ["0591-0369", "0591-0370", "0591-0371", "0591-0372"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LOXAPINE SUCCINATE"], "rxcui": ["311385", "311386", "314075", "314078"], "spl_id": ["cae2db34-6be2-45cf-b9b5-9b929650eb4f"], "spl_set_id": ["a6107bb1-3e23-4c5d-bbf4-5e29deff6728"], "package_ndc": ["0591-0369-01", "0591-0370-01", "0591-0371-01", "0591-0372-01"], "is_original_packager": [true], "upc": ["0305910369019", "0305910370015", "0305910372019"], "unii": ["X59SG0MRYU"]}, "product_type": "Drugs", "event_id": "62383", "recalling_firm": "Watson Laboratories Inc", "address_1": "311 Bonnie Cir", "address_2": "N/A", "postal_code": "92880-2882", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1400-2012", "product_description": "Loxapine Capsules USP, 10mg, 100 count bottle, Rx only, Manufactured By: Watson Laboratories Inc., Corona, CA 92880 Rx only. NDC #  0591-0370-01", "product_quantity": "106,323 bottles", "reason_for_recall": "Labeling: Incorrect or Missing Package Insert:  An outdated version of a patient outsert was used when packaged.", "recall_initiation_date": "20120417", "center_classification_date": "20120629", "termination_date": "20130318", "report_date": "20120711", "code_info": "Lot #s: 107886A, 107887A, 112874A, 144274A, 196483A, 201146A, 217265A, 260747B, 283308A, 313279A, 313279B, 327892A, 327893A, 327894A, 387239A, 387240A, 427259A, 427260A, 456251A."}, {"status": "Terminated", "city": "Pine Level", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62775", "recalling_firm": "Custom Medical Specialties, Inc.", "address_1": "330 East Main Street", "address_2": "N/A", "postal_code": "27568", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "FAX", "distribution_pattern": "GA, MD, MA", "recall_number": "D-1650-2012", "product_description": "CMS-8934 Custom Phlebectomy Tray, Sterile, contains Sodium chloride 0.9% 50 mL, Manufactured by: CMS, Custom Medical Specialties, Inc., 330 East Main St, PO Box 177, Pine level, NC 27568, the tray also contains other components not listed in this product description.", "product_quantity": "20 Trays", "reason_for_recall": "Lack of Assurance of Sterility; the firm's medical trays contain Hospira's 0.9% Sodium Chloride bags which were subject to recall due to leaking bags.", "recall_initiation_date": "20120723", "center_classification_date": "20120817", "termination_date": "20121011", "report_date": "20120829", "code_info": "Lot #: 25915-1111, Exp 12/2012"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "10 units", "code_info": "Rx #'s:  0370793    0400021    0388933          0400021    0397238      0397238", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "PYRIDOXINE 100MG/ML INJECTABLE\t150 ML  \t180 ML  \t300 ML  \t  \t  \t  \t  \t360 ML  \t  \t450 ML  (5 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1609-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "19 units", "code_info": "Rx #'s:  0398081      0397941    0407446    0397941    0398081          0409508    0356693    0374227      0356693      0400766        0374227", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "IOHEXOL 200MG IODINE/ML INJECTABLE\t120 ML  \t  \t300 ML  \t50 ML  \t600 ML  \t72 ML;  \t  \t  \t  IOHEXOL,  4ML VIAL 240MG IODINE/ML INJECTABLE\t200 ML;  IOHEXOL, 3ML VIAL 300MG IODINE/ML INJECTABLE\t180 ML  \t600 ML  \t  \t90 ML  \t  \t  \t  \t  \t900 ML  (10 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1548-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3", "68968-5554-01"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "62002", "recalling_firm": "Noven Pharmaceuticals, Inc.", "address_1": "11960 Sw 144th St", "address_2": "", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1413-2012", "product_description": "Daytrana (Methylphenidate) Transdermal System Patch, Delivers 20 mg over 9 hours (2. 2 mg/hr), 1 patch per pouch (NDC 68968-5554-01) packaged in 3-count patches per box (NDC 68968-5554-3) , Rx only, Manufactured  for Shire US Inc., Wayne, PA 19087 by Noven Pharmaceuticals, Inc., Miami, FL 33816.08/04/12.", "product_quantity": "185,160 patches", "reason_for_recall": "Miscalibrated/Defective Delivery System; exceeded the specification for both mechanical peel force (MPF) and/or the z-statistic value", "recall_initiation_date": "20120322", "center_classification_date": "20120712", "termination_date": "20140509", "report_date": "20120718", "code_info": "Lot # 53995", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "3 units", "code_info": "Rx #\"s:  0392538    0391562    0391564", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "CISPLATIN 1MG/ML INJECTABLE 1000 ML, 2000 ML (2 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1485-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Pine Level", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62775", "recalling_firm": "Custom Medical Specialties, Inc.", "address_1": "330 East Main Street", "address_2": "N/A", "postal_code": "27568", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "FAX", "distribution_pattern": "GA, MD, MA", "recall_number": "D-1649-2012", "product_description": "Custom Access Tray, Sterile, contains Sodium Chloride 0.9% 50 mL, Re-order #: CMS-1667-R2(94-2478), Manufactured for KM Medical, Inc., 124 Jewett Street, Georgetown, MA 01833, the tray also contains other components not listed in this product description.", "product_quantity": "35 Trays", "reason_for_recall": "Lack of Assurance of Sterility; the firm's medical trays contain Hospira's 0.9% Sodium Chloride bags which were subject to recall due to leaking bags", "recall_initiation_date": "20120723", "center_classification_date": "20120817", "termination_date": "20121011", "report_date": "20120829", "code_info": "Lot #: 25744-1111, Exp 09/2012"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "79 units", "code_info": "Rx #'s:   0402964    0402963    0398083        0398557    0398524      0406883    0396497    0401829    0407441    0408458    0408393    0398196    0398084        0405518    0397074      0401694    0401412    0398196    0404325      0397888    0407444    0408529    0408099    0401897            0402614    0405996    0402614    0405382      0398014    0398022    0400197      0400116    0400197      0401897    0405996    0398014      0402614    0398014    0401755    0401755      0404391      0402616      0401688    0398026    0399744      0402617      0398026    0401755    0398026    0402616    0400850    0404643    0408996    0403960    0400509    0400960    0403759    0404643    0405771", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "BUPIVACAINE HCL & EPINEPHRINE, P.F. 0.25% / 1:200,000 INJECTABLE 900 ML; BUPIVACAINE HCL & EPINEPHRINE, P.F. 0.5% / 1:200,000 INJECTABLE 900 ML; BUPIVACAINE HCL 0.25% INJECTABLE 120 ML,180 ML, 240 ML, 250 ML, 300 ML, 500 ML, 60 ML; BUPIVACAINE HCL 0.5% INJECTABLE1000 ML, 120 ML, 200 ML, 250 ML, 400 ML, 50 ML, 500 ML, 600 ML, 750 ML; BUPIVACAINE HCL, P.F. 0.25% INJECTABLE\t1000 ML, 120 ML, 1200 ML, 150 ML, 1500 ML, 180 ML, 240 ML, 300 ML, 60 ML, 600 ML, 900 ML; BUPIVACAINE HCL, P.F. 0.5% INJECTABLE 10 ML, 120 ML, 1500 ML, 20 ML, 200 ML, 240 ML, 2500 ML, 300 ML, 360 ML, 600 ML, 960 ML; BUPIVACAINE HCL, P.F. 0.75% INJECTABLE 1200 ML, 150 ML, 240 ML, 30 ML, 600 ML, 7 ML (47 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1470-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "13 units", "code_info": "Rx #'s:   0381590                    0384915    0381590      0384915", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "PHENYLEPH/DICLOF/TROPIC/PROPARAC/POVIDONE IODINE SOL. 10%/0.1%/1%/0.5%/5% OPHTHA\t10 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t2 ML  \t20 ML  \t  \t3 ML  (4 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1598-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "2 units", "code_info": "Rx #'s:N0391834  N0401851", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "BUPIVACAINE/FENTANYL IN SODIUM CHLORIDE 0.9%  P. F. 30 MG/200 MCG/ML INTRATHECAL\t40 ML (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1474-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "2 units", "code_info": "Rx #'s:   0390477    0400314", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "PENICILLIN G POTASSIUM 10,000U/ML INJECTABLE\t1 ML  (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1596-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:  0388028", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "TWINJECT*** 0.3 MG INJECTABLE\t1 PK  (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1635-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "3 units", "code_info": "Rx #'s:N0392050, N0391605, N0402936", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "BACLOFEN/MORPHINE, P.F. 1,000MCG/25MG/ML INTRATHECAL 18 ML;  BACLOFEN/MORPHINE, P.F. 1,500MCG/1.5MG/ML INTRATHECAL 40 ML;  BACLOFEN/MORPHINE, P.F. 2,000MCG/25MG/ML INTRATHECAL 40 ML (3 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1462-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "5 units", "code_info": "Rx #'s:  0397687      0366647    0366647", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "VANCOMYCIN/DEXAMETHASONE, LYOPHILIZED 1%/0.1% KIT\t2 KIT  \t  \t20 KIT  \t24 KIT  \t  (3 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1639-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "5 units", "code_info": "Rx #'s:  0392224    0378833    0402369    0360916    0402369", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "DICLOFENAC SODIUM, SDPF - (0.1ML SYRINGE, 30G, 1/2\") 500MCG/0.1ML INJECTABLE 0.5 ML, 2 ML, 4 ML (3 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1502-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "3 units", "code_info": "Rx #'s:  0398939    0389889    0398939", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "COPPER GLUCONATE  2MG/ML INJECTABLE\t30 ML, 60 ML (2 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1487-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "7 units", "code_info": "Rx #'s:  0399208    0385915", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "MITOMYCIN/LIDOCAINE/EPINEPHRINE 0.04%/0.02%/0.1% INJECTABLE\t5 ML;  MITOMYCIN/LIDOCAINE/EPINEPHRINE 0.08MG/13.3MG/6.7MCG/ML INJECTABLE\t0.2 ML  (2 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1583-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "WILMINGTON", "state": "DE", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA022101"], "brand_name": ["NEXIUM"], "generic_name": ["ESOMEPRAZOLE MAGNESIUM"], "manufacturer_name": ["AstraZeneca Pharmaceuticals LP"], "product_ndc": ["0186-4010", "0186-5020", "0186-4020", "0186-4040", "0186-5040", "0186-4025", "0186-4050"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ESOMEPRAZOLE MAGNESIUM"], "rxcui": ["606726", "606728", "606730", "606731", "692576", "692578", "861568", "861570", "861576", "861583", "1297658", "1297660", "1297761", "1297763"], "spl_id": ["e84bdda0-3dbf-4166-9ce2-13ee23629029"], "spl_set_id": ["f4853677-1622-4037-688b-fdf533a11d96"], "package_ndc": ["0186-5020-31", "0186-5020-54", "0186-5020-82", "0186-4010-01", "0186-4010-02", "0186-4020-01", "0186-4040-01", "0186-4040-02", "0186-5040-31", "0186-5040-35", "0186-5040-55", "0186-5040-85", "0186-5040-54", "0186-5040-82", "0186-5040-05", "0186-4025-01", "0186-4025-02", "0186-4050-01"], "is_original_packager": [true], "unii": ["R6DXU4WAY9"], "upc": ["301865040850"]}, "product_type": "Drugs", "event_id": "62439", "recalling_firm": "ASTRA ZENECA Lp", "address_1": "1800 CONCORD PIKE", "address_2": "", "postal_code": "19803-2902", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1410-2012", "product_description": "Nexium (esomeprazole magnesium) Delayed-Release Capsules, 40 mg, 1000-count bottle, Rx only, Manufactured for: AstraZeneca LP, Wilmington, DE  19850; By: AstraZeneca AB, S-151 85 Sodertalje, Sweden, NDC 0186-5040-85, UPC 3 0186-5040-85 0.", "product_quantity": "2,556 bottles", "reason_for_recall": "Adulterated Presence of Foreign Tablets/Capsules: Some bottles may contain a small number of Nexium 20 mg capsules intended for the Japanese market in addtion to Nexium 40 mg capsules.", "recall_initiation_date": "20120702", "center_classification_date": "20120711", "termination_date": "20130411", "report_date": "20120718", "code_info": "Lot #: H008328, Exp 11/14", "more_code_info": ""}, {"country": "United States", "city": "Norman", "address_1": "623 N Porter Ave Ste 100", "reason_for_recall": "CGMP Deviations; no identity or purity testing on incoming oxygen gas, and lack of documentation", "address_2": "", "product_quantity": "861 cylinders", "code_info": "All lots distributed January 1, 2011 - October 18, 2011.", "center_classification_date": "20120808", "distribution_pattern": "OK", "state": "OK", "product_description": "OXYGEN, COMPRESSED USP MEDICAL GAS in the following containers:  E Cylinder 680L, D Cylinder 425L, and M6 Cylinder 165L, Rx only, Oklahoma Respiratory Care, Norman, OK", "report_date": "20120815", "classification": "Class II", "openfda": {}, "recalling_firm": "Oklahoma Respiratory Care Inc", "recall_number": "D-1445-2012", "initial_firm_notification": "Visit", "product_type": "Drugs", "event_id": "62698", "termination_date": "20130802", "more_code_info": "", "recall_initiation_date": "20120621", "postal_code": "73071-6000", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62421", "recalling_firm": "VistaPharm, Inc.", "address_1": "7265 Ulmerton Rd", "address_2": "N/A", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1440-2012", "product_description": "Xactdose Phenytoin Oral Suspension, USP 125 mg/5mL, supplied in 5 mL unit dose cups, VISTAPHARM, Largo, FL  NDC 66689-036-50", "product_quantity": "27,221 unit dose cups", "reason_for_recall": "Defective container; lidding deformity allows the contained product to transpire causing potential viscosity and assay failures. The viscosity and assay failures were due to the loss of moisture. The loss of moisture caused the viscosity to increase and assay to increase relative to the sample volume.", "recall_initiation_date": "20110930", "center_classification_date": "20120802", "termination_date": "20131212", "report_date": "20120808", "code_info": "Lot #'s 210900, 214000, 220100, 224800, 228700, 232800"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "4 units", "code_info": "Rx #'s:    0402610    0406777    0407425    0407640", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "FORSKOLIN/PAPAVARINE/PHENTOLAMINE 200MCG/40MG/3MG/ML INJECTABLE 5 ML; FORSKOLIN/PAPAVARINE/PHENTOLAMINE/ALPROSTADIL 100MCG/30MG/1MG/30MCG/ML INJECTABL 10 ML; (2 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1523-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Shenandoah", "address_1": "604 W Thomas Ave", "reason_for_recall": "Subpotent (Single Ingredient Drug): Low assay at the 9-month test interval.", "address_2": "Po Box 130", "product_quantity": "1,924,297 bulk tablets", "code_info": "Lot HB06311", "center_classification_date": "20120622", "distribution_pattern": "Nationwide and PR.", "state": "IA", "product_description": "Thyro-Tab 0.050mg., packaged in bulk drums for repackaging.  The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.", "report_date": "20120704", "classification": "Class II", "openfda": {}, "recalling_firm": "Lloyd Inc", "recall_number": "D-1392-2012", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "61094", "termination_date": "20130730", "more_code_info": "", "recall_initiation_date": "20120203", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "6 units", "code_info": "Rx #'s:N0407992, N0387607, N0394440, N0402003, N0409979, N0399632", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "BACLOFEN/HYDROMORPHONE, P.F. 2000MCG/2.9MG/ML INTRATHECAL 20 ML; BACLOFEN/HYDROMORPHONE, P.F. 2000MCG/6MG/ML INTRATHECAL 40 ML; BACLOFEN/HYDROMORPHONE, P.F. 500MCG/50MG/ML INTRATHECAL 40 ML (2 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1461-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62772", "recalling_firm": "Prometheus Laboratories Inc.", "address_1": "9410 Carroll Park Dr", "address_2": "N/A", "postal_code": "92121-5201", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico.", "recall_number": "D-1659-2012", "product_description": "Mercaptopurine Tablets, USP, 50 mg, packaged in a) 60-count tablets per bottle (NDC 49884-922-02) and b) 250-count tablets per bottle (NDC 49884-922-04), Rx only, Distributed by: Par Pharmaceutical Companies, Inc., Spring Valley, NY  10977.", "product_quantity": "a) 25,516 bottles; b) 2,569 bottles", "reason_for_recall": "Failed USP Dissolution Test Requirements: The recalled lots do not meet the specification for dissolution.", "recall_initiation_date": "20120629", "center_classification_date": "20120822", "termination_date": "20130327", "report_date": "20120829", "code_info": "Lot #s: a) 11A003, 11A004, 11A005, Exp 01/13; 11L071, 11L072, Exp 10/13; b) 11B009, Exp 01/13; 11L073, Exp 10/13"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #'s:   0402124", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "VANADYL SULFATE SOLUTION 200MCG/ML INJECTABLE\t60 ML  (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1637-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA011719"], "brand_name": ["METHOTREXATE"], "generic_name": ["METHOTREXATE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["61703-350", "61703-408"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["METHOTREXATE SODIUM"], "rxcui": ["1655956", "1946772"], "spl_id": ["95b8b8da-da4e-4bba-9038-3cf65f3d5c1a"], "spl_set_id": ["0d63ba29-b692-41b4-87e8-351265c8273f"], "package_ndc": ["61703-350-37", "61703-350-38", "61703-408-41"], "is_original_packager": [true], "unii": ["3IG1E710ZN"]}, "product_type": "Drugs", "event_id": "62459", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, including Puerto Rico and Guam.    Product was also distributed internationally to Australia, Belgium, Canada, France, Germany, Korea, Malaysia, New Zealand, Norway, Pakistan, Philippines, Portugal, Singapore, Sweden, Thailand and  Vietnam", "recall_number": "D-1681-2012", "product_description": "Methotrexate Injection, USP, 25 mg/mL, 40 mL Single Dose Vial, Rx only, antineoplastic/cytotoxic agent; Manufactured for Hospira, Inc., Lake Forest, IL 60045, Product of Australia; NDC 61703-408-41", "product_quantity": "34,572 vials", "reason_for_recall": "The affected lots of Carboplatin Injection, Cytarabine  Injection, Methotrexate Injection, USP, and Paclitaxel Injection are being recalled due to visible particles embedded in the glass located at the neck of the vial. There may be the potential for product to come into contact with the embedded particles and the particles may become dislodged into the solution.", "recall_initiation_date": "20120627", "center_classification_date": "20120919", "termination_date": "20161215", "report_date": "20120926", "code_info": "lot number Y064457AA, exp OCT 2013    Rest of world lot numbers:   list M4457A001, lot number Y054457AB, exp SEP 2013", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "6 units", "code_info": "Rx #'s:   0384231        0384231", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "MOXIFLOXACIN  150MCG/0.1ML (1.5MG/ML) INJECTABLE\t10 ML  \t  \t  \t20 ML  (2 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1586-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "16 units", "code_info": "Rx #'s:C0392008  C0401692  C0401728  C0392845  C0398970  C0401801  C0402374  C0392845  C0396878  C0391291  C0402620  C0403051  C0396889  C0401679  C0402560  C0394688", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "MIDAZOLAM 1MG/ML (5ML VIAL) INJECTABLE\t100 ML;  MIDAZOLAM 1MG/ML INJECTABLE\t100 ML  \t  \t108 ML  \t1250 ML  \t  \t20 ML  \t292 ML  \t300 ML  \t40 ML  \t500 ML  \t90 ML;  MIDAZOLAM 5MG/ML INJECTABLE\t140 ML  \t150 ML  \t200 ML;  MIDAZOLAM HCL ***(10X10ML) 5MG/ML INJECTABLE\t100 MLS  (13 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1580-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "2 units", "code_info": "Rx #: T0389114", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "ACETIC ACID, IRRIGATION  3% SOLUTION 500 ML (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1448-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "27 units", "code_info": "Rx #'s:  0404160,  0404162,  0404697,  0405589,  0407510,  0407568,  0407772,  0409510,  0409877,  0410186,  0404478,  0405838,  0406815,  0406819,  0405467,  0407857,  0404470,  0404712,  0406839,  0406523,  0407706,  0405838,  0405842,  0406839", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "BACTERIOSTATIC SODIUM CHLORIDE 10ML VIAL** 0.9% INJECTABLE 10 ML, 10 MLS, 100 ML, 120, 20 MLS, 200 ML, 30 MLS, 40 ML, 50 ML, 50 MLS (10 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1463-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Fort Washington", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "61872", "recalling_firm": "Mcneil Consumer Healthcare, Div Of Mcneil-ppc, Inc.", "address_1": "7050 Camp Hill Rd", "address_2": "N/A", "postal_code": "19034-2210", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1404-2012", "product_description": "Imodium Multi-Symptom Relief Caplets, Loperamide HCl 2 mg/Simethicone 125 mg, 18 count blister pack cartons, McNeil Consumer Healthcare, Div of McNeil-PPC Inc., Fort Washington, PA", "product_quantity": "53,892 packages", "reason_for_recall": "Defective Container; damaged blister units", "recall_initiation_date": "20120517", "center_classification_date": "20120702", "termination_date": "20130411", "report_date": "20120711", "code_info": "Lot #CMF023, Expiration 07/13."}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "311 units", "code_info": "Rx #'s:  0408845 0400308 0404146 0404314 0404734 0405632 0406573 0406701 0407236 0407894 0409557 0408043 0408222 0403792 0404381 0404597 0404937 0405274 0405602 0405880 0405881 0405889 0406307 0406538 0406558 0407551 0410050 0410051 0410054 0410335 0403801 0404660 0405429 0406714 0404383 0404424 0404429 0404431 0408668 0404381 0405641 0403996 0404175 0404381 0404598 0404985 0405057 0405274 0405520 0405687 0406286 0406538 0406573 0406905 0407288 0408084 0408783 0408855 0410229 0410380 0404381 0409102 0404479 0405889 0404597 0404661 0404881 0405520 0405836 0405881 0406558 0405174 0404381 0406372 0407748 0405429 0403860 0403862 0404014 0404169 0404533 0404735 0405599 0405896 0406440 0406612 0406750 0407072 0407940 0408312 0408462 0408930 0409264 0410399 0404881 0405639 0405654 0405882 0405883 0406752 0407396 0404682 0408308 0404383 0404381 0404328 0406996 0409438 0404660 0404183 0404435 0405283 0405348 0406510 0406660 0407382 0407748 0407844 0409421 0409755 0404159 0405637 0405926 0406895 0407005 0405084 0405180 0409839 0405174 0404014 0404171 0404187 0404314 0404526 0405237 0405472 0405522 0405871 0405896 0407001 0408598 0408601 0408761 0408821 0410024 0403801 0404159 0406339 0406752 0404659 0407005 0405884 0405897 0403788 0404014 0404184 0404624 0406610 0408898 0406161 0404937 0408175 0406989 0404001 0404002 0406671 0404133 0404146 0404171 0404172 0404182 0404381 0404435 0404526 0404529 0404530 0404531 0404533 0404608 0404620 0404732 0404846 0404875 0404904 0404979 0405171 0405347 0405348 0405687 0405879 0405910 0406151 0406207 0406286 0406491 0406520 0406560 0406612 0406680 0406892 0407001 0407240 0407580 0407585 0408487 0409058 0409077 0409494 0409554 0409582 0409590 0409592 0409846 0409848 0410323 0406325 0406895 0395514 0404133 0404314 0406829 0395514 0353249 0395514 0404533 0404598 0404734 0404742 0405676 0405887 0406902 0407236 0407462 0407757 0407802 0408372 0408752 0408833 0404479 0404381 0404531 0404573 0405522 0405925 0404617 0405428 0408161 0405428 0405428 0399738 0408376 0408385 0406368 0405178 0404163 0409151 0405049 0406485 0405049 0408044 0405181 0406845 0389952 0404159 0404163 0406848 0404833 0408322 0404829 0408324", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "WATER BACT STERILE - (25X30ML)***  INJECTABLE\t30 ML  \t750 MLS;  WATER STERILE - USP (25X10ML)*  INJECTABLE\t10 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t10 MLS  \t  \t100 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t100 MLS  \t  \t  \t  \t1000 ML  \t  \t  \t  \t  \t  \t  \t110 ML  \t  \t120 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t130 ML  \t  \t130 MLS  \t150   \t150 ML  \t  \t  \t  \t  \t  \t  \t150 MLS  \t160 ML  \t  \t  \t160 MLS  \t20   \t  \t20 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t200 ML  \t  \t  \t  \t  \t  \t  \t  \t200 MLS  \t  \t2000 ML  \t230 ML  \t240 ML  \t  \t250 ML  \t250 MLS  \t30 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t30 MLS  \t  \t  \t  \t  \t300   \t300 ML  \t  \t  \t  \t300 MLS  \t  \t40 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t40 MLS  \t  \t400 ML  \t  \t400 MLS  \t  \t50   \t  \t  \t50 ML  \t  \t  \t  \t  \t  \t50 MLS  \t500 ML  \t  \t500 MLS  \t60   \t  \t  \t60 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t60 MLS  \t  \t6800 ML  \t70 ML  \t  \t  \t7240 ML  \t7500 ML  \t  \t  \t80 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t80 MLS  \t90 ML;  \t  \t  \t  WATER STERILE - USP (25X20ML)**  INJECTABLE\t1000 MLS  \t200 ML  \t200 MLS  \t  \t300 MLS  \t400 MLS  \t500 ML  \t60   \t60 ML  \t600 20  \t600 ML;  WATER STERILE - USP (25X50ML)**  INJECTABLE\t1000 ML  \t  \t  \t1150 ML  \t1250 MLS  \t1350 ML  \t150 MLS  \t2500 ML  \t300 ML  \t50 ML  \t  \t  \t500 ML  \t500 MLS  \t600   \t600 ML  \t600 MLS  (72 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1643-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ronkonkoma", "address_1": "2 Fleetwood Ct", "reason_for_recall": "Microbial contamination of Non Sterile Product; contamination with Burkholderia cepacia (manufacturer)", "address_2": "", "product_quantity": "", "code_info": "Antiseptic wipes shipped since July 02, 2009. Lots:  JT14509,  JT15209, JT20609, JT20909, JT23709, JT27809,  JT32809, JT00710,  JT15810,  JT18310,  JT18810,  JT23210,  JT25810,  JT27610,  JT31510,  JT35610,  JT35911,  JT04811,  JT05311,  JT11811,  JT15211,  JT15911,  JT18211,  JT18211,  JT21511-1,  JT26311,  JT30711,  JT22011-1,  JT01012,  JT04112,  JT06512, JT07512, JT07710,  JT14509, JT15209,  JT21409,  JT20609, JT33009,  JT00710,  JT18810, JT23210,  JT35911,  JT05311,  JT11811,  JT26311,  JT01012,  JT14509,  JT15209,  JT20609,  JT15209,  JT23709,  JT27809,  JT00710,  JT00710,  JT18310,  JT18810,  JT23210,  JT23210,  JT27610,  JT31510, JT05809,  JT14509,  JT15209,  JT21209,  JT27809,  JT12510,  JT15810,  JT18310,  JT11811,  JT13211,  JT15911,  JT35911,  JT01012,  JT30711", "center_classification_date": "20120917", "distribution_pattern": "Nationwide", "state": "NY", "product_description": "ZEE Antiseptic Wipes, First Aid Antiseptic, Benzalkonium chloride 0.133% (effective concentration), over the counter; supplied in 10 (item 2633), 50 (items 0204 and 02040 [sold in Canada only]) and 100 (item 0271) wipes per box distributed by ZEE MEDICAL, INC., Irvine, CA", "report_date": "20120926", "classification": "Class II", "openfda": {}, "recalling_firm": "Dukal Corp.", "recall_number": "D-1675-2012", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "62320", "termination_date": "20130621", "more_code_info": "", "recall_initiation_date": "20120614", "postal_code": "11779-6907", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "3 units", "code_info": "Rx #'s:  0399566    0389886    0407257", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "HYALURONIC ACID SODIUM SALT  10MG/ML INJECTABLE 100 ML, 20 ML; HYALURONIC ACID SODIUM SALT, P.F. 20MG/ML INJECTABLE 500 ML (3 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1533-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "16 units", "code_info": "Rx #'s:N0396140  N0408047  N0390990  N0400772  N0387610  N0391586  N0393141  N0396643  N0398235  N0402376  N0404186  N0409166  N0410206  N0387612  N0394426  N0402375", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "BUPIVACAINE/MORPHINE SULFATE, P.F. 2.5MG/10MG/ML INTRATHECAL 40 ML; BUPIVACAINE/MORPHINE SULFATE, P.F. 7.5MG/25MG/ML INTRATHECAL 20 ML; BUPIVACAINE/MORPHINE SULFATE, P.F. 7.5MG/50MG/ML INTRATHECAL 18 ML, 35 ML (4 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1478-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "38 units", "code_info": "Rx #'s:   0396112    0396112    0390633    0399923    0392295    0397930    0405691    0357875    0371933      0370806      0371933      0357875    0371933      0373258    0373258    0373258    0391775      0397909    0391540    0371152    0401946    0409588    0391886              0391886    0391886    0391886    0391867    0400517", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "VITAMIN  K (PHYTONADIONE) 10MG/ML INJECTABLE\t1 ML  \t2 ML  \t4 ML;  VITAMIN  K (PHYTONADIONE) 5MG/ML INJECTABLE\t2 ML;  VITAMIN A AQUEOUS EMULSION 50,000 U/ML INJECTABLE\t20 ML  \t40 ML;  \t  VITAMIN B COMPLEX (B1,B2,B3,B5,B6) 100/5/100/100/100MG/ML INJECTABLE\t120 ML  \t  \t  \t150 ML  \t  \t  \t  \t180 ML  \t90 ML  \t  VITAMIN B COMPLEX (B1,B2,B3,B5,B6,B12)  INJECTABLE\t10 ML  \t20 ML  \t40 ML  VITAMIN B COMPLEX (B1,B2,B3,B5,B6/ASCORBIC ACID/B12) 12.5/2/12.5/5/5/1MG/1MG/ML \t60 ML  \t  VITAMIN B COMPLEX -PF  (B1,B2,B3,B5,B6) 12.5/12.5/12.5/12.5/12.5MG/ML INJECTABLE\t40 ML  VITAMIN B COMPLEX PF (B1,B2,B3,B5,B6,B12)  INJECTABLE\t10 ML  VITAMIN B-6/VITAMIN B-12 100MG/1000MCG/ML INJECTABLE\t5 ML  VITAMIN B-COMPLEX 100*** (30ML)  INJECTABLE\t30 ML  \t  VITAMIN COMPLEX (ASCOR,B1,B2,B3,B5,B6,B12,METH,INOS,CHL,LID) DR. HOLLOWAY INJECT\t180 ML  \t  \t  \t  \t  \t  \t240 ML  \t30 ML  \t60 ML  VITAMIN D3  IN SESAME OIL 10,000 IU/ML INJECTABLE\t60 ML  (23 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1641-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "6 units", "code_info": "Rx #'s:   0362307    0404196    0395753    0395753    0388923    0364468", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "PHENTOLAMINE 10MG/ML INJECTABLE\t6 ML;  \t  PHENTOLAMINE 1MG/ML INJECTABLE\t2 ML  \t5 ML;  PHENTOLAMINE 5MG/ML INJECTABLE\t20 ML  \t50 ML  (5 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1597-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "72 units", "code_info": "Rx #'s:   0403290    0405427    0382085      0403290    0382085    0405142    0391560      0391560      0382085    0362356    0362504    0376747    0398606    0405426    0362504        0362504    0376747    0402778    0405426    0395599    0395599    0405112    0406366    0388985      0391567      0396672    0405426    0395599    0398606    0360280      0385032      0390726    0402210      0398232    0360280      0362394    0393068    0403288    0360025          0369905          0379934    0393068    0402985    0403256    0399150    0360025    0372389    0399150    0402985    0399150    0403288    0372389    0393068    0398232    0360280    0362394    0393068    0398232", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "LEUCOVORIN, LYOPHILIZED 100 MG VIAL INJECTABLE\t1 VIAL  \t10 VIAL  \t100 VIAL  \t  \t2 VIAL  \t24 VIAL  \t30 VIAL  \t50 VIAL  \t  \t60 VIAL  \t  \t76 VIAL;  LEUCOVORIN, LYOPHILIZED 350 MG VIAL INJECTABLE\t10 VIAL  \t  \t  \t  \t  \t15 VIAL  \t  \t  \t20 VIAL  \t  \t  \t  \t22 VIAL  \t28 VIAL  \t30 VIAL  \t  \t4 VIAL  \t  \t40 VIAL  \t  \t  \t5 VIAL  \t50 VIAL  \t8 VIAL;  LEUCOVORIN, LYOPHILIZED 500 MG VIAL INJECTABLE\t10 VIAL  \t  \t  \t  \t  \t  \t  \t14 VIAL  \t15 VIAL  \t  \t17 VIAL  \t  \t2 VIAL  \t20 VIAL  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t23 VIAL  \t25 VIAL  \t  \t  \t  \t27 VIAL  \t3 VIAL  \t30 VIAL  \t33 VIAL  \t36 VIAL  \t5 VIAL  \t50 VIAL  (35 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1555-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "15 units", "code_info": "Rx #'s:  0404547,  0404385,  0410167,  0410170,  0410171,  0404102,  0404102,  0404547,  0380221,  0373088,  0398747,  0390360,  0402572", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "AMPHOTERICIN B OPHTHALMIC (0.5ML, LL SYRINGE) P.F. 10MCG/0.1ML INJECTABLE 1 ML, 1.5 ML, 2 ML, 2.5 ML, 5 ML; AMPHOTERICIN B OPHTHALMIC 5MCG/0.1ML INJECTABLE, 0.2 ML, 0.4 ML, 3 ML; AMPHOTERICIN B, LYOPHILIZED 150MCG INJECTABLE\t2 VIAL; AMPHOTERICIN-B, NEBULIZATION, STERILE 5MG/2ML NASO-NEB 60 ML (10 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1456-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Streetsboro", "state": "OH", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "62761", "recalling_firm": "Natural Essentials Inc", "address_1": "1800 Miller Pkwy", "address_2": "N/A", "postal_code": "44241-5067", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-1671-2012", "product_description": "Oasis Age Essential (cetylpyridinium chloride) Mouthwash, 0.06%, 473 mL (16 fl oz) bottle, Oasis Consumer Healthcare LLC, 812 Huron Road, Cleveland, Ohio 44115, UPC 8 51076 00300 2.", "product_quantity": "11,058 bottles", "reason_for_recall": "Microbial Contamination of a Non-Sterile Products: Three product lots are contaminated with Burkholderia cepacia.", "recall_initiation_date": "20120727", "center_classification_date": "20120830", "termination_date": "20140110", "report_date": "20120905", "code_info": "Lot #: 11741, 11842, 11851, Exp 05/14"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "5 units", "code_info": "Rx #'s:   0392909    0392909    0392909    0387234    0392909", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "PHENYLEPHRINE/TROPICAMIDE/PROPARACAINE SOLUTION 2.5%/1%/0.5% OPHTHALMIC\t120 ML  \t25 ML  \t30 ML  \t5 ML  \t90 ML  (5 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1601-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Hicksville", "address_1": "55 Cantiague Rock Road", "reason_for_recall": "Chemical Contamination: This product is being recalled because trace amounts of a plasticizer (Di-Octyl Phthalate) may be present in the product.", "address_2": "", "product_quantity": "444 bottles", "code_info": "Lot #: 418N, Exp 06/13", "center_classification_date": "20120725", "distribution_pattern": "Nationwide.", "state": "NY", "product_description": "Erythromycin Topical Solution USP, 2%, 60 mL bottle with applicator, Rx only. E. FOUGERA & CO., A division of Fougera Pharmaceuticals, Inc., Melville, New York 11747, NDC 0168-0215-60, UPC 3 0168-0215-60 0.", "report_date": "20120801", "classification": "Class III", "openfda": {}, "recalling_firm": "Fougera Pharmaceuticals, Inc.", "recall_number": "D-1426-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62136", "termination_date": "20151130", "more_code_info": "", "recall_initiation_date": "20120607", "postal_code": "11801-1126", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "4 units", "code_info": "Rx #'s:    0392297      0392297    0395407", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "MEPIVACAINE HCL/EPINEPHRINE. 2%/1:100,000 (0.001%) INJECTABLE\t30 ML  \t  \t60 ML;  MEPIVICAINE HCL 3% (30MG/ML) INJECTABLE\t6 MLS  (3 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1570-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "448 units", "code_info": "Rx #'s:  0384355, 0389246, 0392332, 0399800, 0407377, 0385460, 0389158, 0402762, 0385460, 0359057, 0385462, 0396242, 0385462, 0391321, 0372399, 0400437, 388360, 0350745, 0354900, 0357950, 0365803, 0391686,  0393285, 0393620, 0395404, 0399228, 0399302, 0401675, 0401844, 0403731, 0406162, 0408427, 0409073, 0399228, 0371562, 0376422, 0396380, 0405576, 0405582, 0405586, 0384289, 0366702, 0360431, 0408278, 0390548, 0396007, 0401479, 0352078, 0352368, 0354526, 0354595, 0357480, 0358685, 0359207, 0363768, 0364549, 0368498, 0369212    0373766    0374428    0375279    0375571    0375873    0377397    0380000    0380005    0381659    0382914    0384657    0386665    0387419    0387519    0387699    0388026    0388292    0388330    0388766    0389900    0390082    0390315    0391607    0392449    0392525    0392848    0393087    0393381    0393499    0393828    0393904    0394395    0394985    0395878    0395912    0396010    0396019    0396120        0396163    0396207    0396267    0396366    0396906    0397063    0397523    0397527    0397728    0398291    0398862    0399237    0399251    0399644    0399898    0401001    0401380    0401414    0401480    0401858    0401991    0402382    0402634    0403182    0403417    0404396    0404958    0404962    0404965    0405377    0405697    0406246    0406753    0406809    0407466    0407512    0407521    0407830    0408706    0408768    0408828    0409007    0409150    0409158    0409809    0388728    0409113    0395179    0401812    0380005    0390728    0408848    0357188    0380005    0388326    0388531    0398590    0407315    0359319    0379979    0380005    0398376    0406549    0390081    0390728    0406512    0350594    0351237    0354526    0358579    0358794    0361059    0362431    0363752    0367108    0367355    0368710    0369213    0369806    0369811    0370264    0370618    0373793    0375571    0378322    0378326    0378513    0378942    0379218    0379983    0380003    0380005    0380149    0382749    0383556    0386269    0386665    0387095    0387179    0387861    0388633    0388634    0388636    0388637    0388638    0388641    0388894    0389374    0389385    0389548    0389790    0390777    0390779    0390781    0390782    0390784    0390790    0392100    0392378    0392380    0392388    0392390    0392508    0392649    0393106    0393111    0393112    0393114    0393115    0393117    0393118    0393836    0393838    0393839    0393841    0393843    0393846    0393848    0394141    0394181    0395615    0395620    0395622    0395623    0395625    0395628    0395632    0395635    0395636    0395921    0396045    0396534    0397327    0397406    0397473    0397475    0397476    0398304    0398372    0399460    0399467    0399469    0399471    0399476    0399478    0399481    0399841    0400028    0400032    0400169    0400782    0400791    0401362    0401477    0402466    0402681    0402687    0402699    0402709    0402711    0402713    0402715    0403292    0403743    0404300    0404953    0405053    0405058    0405061    0405264    0405284    0405391    0405392    0405394    0405850    0405855    0405863    0405866    0406896    0407031    0407430    0407614    0407619    0407623    0407625    0407626    0407631    0407708    0407758    0407835    0407845    0408266    0408719    0408839    0409260    0409369    0409644    0409663    0409666    0409667    0409672    0409676    0409685    0409803    0409810    0409811    0409984    0410385    0376121    0388330    0398376    0402184    0354526    0380005    0384306    0402150    0380005    0395412    0351617    0377040    0405279    0351625    0398027    0400613    0405073    0356174    0366355    0366652    0372365    0377239    0377604    0384197    0384239    0388883    0389914    0390003    0392798    0393394    0393804    0396191    0396863    0398155    0400682    0401354    0402361    0402772    0406281    0407525    0408139    0408807    0366728    0395638    0392966    0402974    0405261    0397156    0390549    0405381    0359548    0381259    0390539    0396023    0405381    0359548    0405381    0388337    0391331    0395269    0408053    0392770    0360349    0382004    0394651    0404245    0406333    0397786    0394838    0389554    0395413    0397465    0395413    0395411    0395411", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "BIMIX   30MG / 4MG INJECTABLE 10 ML, 5 ML; BIMIX   30MG / 5MG INJECTABLE 10 ML; BIMIX   9MG / 0.25MG INJECTABLE 10 ML, 5 ML; BIMIX  15MG / 1MG INJECTABLE 10 ML; BIMIX  18MG / 0.5MG INJECTABLE 10 ML, 5 ML; BIMIX  18MG / 1MG INJECTABLE 5 ML; BIMIX  20MG / 0.75MG INJECTABLE 5 ML; BIMIX  26MG/1MG/ML INJECTABLE 10 ML; BIMIX  26MG/2MG/ML INJECTABLE 20 ML; BIMIX  30MG / 0.5MG INJECTABLE 10 ML, 20 ML,5 ML, 50 ML, 60 ML; BIMIX  30MG / 1.5MG INJECTABLE 5 ML; BIMIX  30MG/1MG INJECTABLE 1 ML, 10 ML, 10 MLS,\t12 ML, 150 ML, 2 ML, 20 ML, 20 MLS, 3 ML, 30 ML, 40 ML, 5 ML, 5 MLS, 50 ML, 6 ML, 60 ML, 7 ML; BIMIX  9MG / 0.5MG/ML INJECTABLE 5 ML; BIMIX 15MG / 0.5MG INJECTABLE 10 ML, 5 ML; BIMIX 16.6MG / 0.55MG/ML INJECTABLE 10 ML, 4.5 ML; BIMIX 30MG / 2MG INJECTABLE 10 ML, 5 ML; BIMIX 30MG/3MG/ML INJECTABLE 10 ML, 5 ML; BIMIX 40MG/2MG INJECTABLE 10 ML, 3 ML, 6 ML; BIMIX 40MG/3MG INJECTABLE 3 ML; BIMIX, SDSM  9MG / 0.25MG INJECTABLE 10 ML; BIMIX, SDSM  9MG / 0.5MG INJECTABLE 10 ML; BIMIX, SDSM 18MG / 0.5MG INJECTABLE 10 ML, 10 MLS; BIMIX, SDSM 30MG / 1.5MG INJECTABLE 10 ML, 10 MLS, 5 ML, 5 MLS; BIMIX, SDSM 30MG / 1MG INJECTABLE 10 ML, 5 ML (58 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1466-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "73 units", "code_info": "Rx #'s:  0406046    0397385    0366980      0395509    0387345    0387381    0387586    0387752    0391041    0391584    0394112    0394246    0395288    0397054    0397946    0399555    0400910    0401208    0403442    0404123    0408115    0388847    0388144    0388144    0395892    0389202    0373332          0378850    0388550    0392222    0373332      0378850    0388550        0373332    0373332    0378850    0358046    0376175    0392337      0375442    0392337    0377047    0381838        0388945    0407636    0371528        0375458      0375458    0400150    0368414    0366367    0389059    0392819    0407227    0368231    0390906    0405998    0364593    0409797    0364593", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "DEXAMETHASONE  SODIUM PHOSPHATE PF 0.04% OPHTHALMIC 2 ML;  DEXAMETHASONE / LIDOCAINE  0.5%/3% INJECTABLE 30 MLS;  DEXAMETHASONE ACETATE (LA) 8MG/ML INJECTABLE 100 ML; DEXAMETHASONE IONTOPHORESIS, STERILE, P.F. 4MG/ML SOLUTION 20 ML, 30 ML (35 DIFFERENT PRODUCTS)  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t40 ML  DEXAMETHASONE SDPF (0.1ML SYRINGE, 31G, 5/16\" ) 0.4MG/ML INJECTABLE\t0.3 ML  \t0.5 ML  DEXAMETHASONE SODIUM PHOSPHATE (P.F.) 10MG/ML (1%) INJECTABLE\t0.05 ML  \t1 ML  \t16 ML  \t  \t  \t  \t  \t2 ML  \t  \t24 ML  \t  \t  \t3 ML  \t  \t  \t32 ML  \t8 ML  \t  DEXAMETHASONE SODIUM PHOSPHATE (P.F.) 4MG/ML (0.4%) INJECTABLE\t0.4 ML  \t2 ML  \t3 ML  \t  \t5 ML  \t6 ML  DEXAMETHASONE SODIUM PHOSPHATE (P.F.) 80MG/ML (8%) INJECTABLE\t100 ML  \t40 ML  \t  \t  DEXAMETHASONE SODIUM PHOSPHATE (P.F.) 8MG/ML (800MCG/0.1ML) INJECTABLE\t0.1 ML  DEXAMETHASONE SODIUM PHOSPHATE 40MG/ML INJECTABLE\t50 ML  DEXAMETHASONE SODIUM PHOSPHATE 4MG/ML INJECTABLE\t100 ML  \t  \t  \t180 MLS  \t  \t240 MLS  \t30 ML  \t60 ML  DEXAMETHASONE SODIUM PHOSPHATE IN BSS (P.F.) 10MG/ML (1%) INJECTABLE\t1 ML  \t  \t  DEXAMETHASONE SODIUM PHOSPHATE, 30ML VIAL** 4MG/ML INJECTABLE\t30 ML  DEXAMETHASONE SOLUTION - NACL, P.F. 0.1% OPHTHALMIC\t15 ML  \t  \t  DEXAMETHASONE, SDPF - (0.07ML SYRINGE, 30G, 1/2\") 80MG/ML INJECTABLE\t0.35 ML  \t  \t0.7 ML", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1497-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:  0399563", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "L-TRYPTOPHAN  15MG/ML INJECTABLE\t60 ML  (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1567-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "13 units", "code_info": "Rx #'s:   0398595    0400957        0407855      0405521    0398595    0403109    0398595    0398595    0398595    0398595", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "METOCLOPRAMIDE HCL 5MG/ML (10MG/2ML) INJECTABLE\t2 ML  \t20 ML  \t  \t  \t  \t  \t200 ML  \t394 ML  \t400 ML  \t498 ML  \t500 ML  \t6 ML  \t600 ML  (9 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1577-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "6 units", "code_info": "Rx #'s:    0370323            0408943", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "LITHIUM CHLORIDE  5MG/ML INJECTABLE\t30 ML  (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1565-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Weston", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077090"], "brand_name": ["LEFLUNOMIDE"], "generic_name": ["LEFLUNOMIDE"], "manufacturer_name": ["Apotex Corp."], "product_ndc": ["60505-2502", "60505-2503"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEFLUNOMIDE"], "rxcui": ["205284", "205285"], "spl_id": ["ebee26d4-bf2a-e0eb-b0f4-e1212d0bed03"], "spl_set_id": ["753453c5-8a7a-878e-3ce7-1d1edce718a9"], "package_ndc": ["60505-2502-1", "60505-2502-2", "60505-2502-3", "60505-2503-1", "60505-2503-2", "60505-2503-3"], "is_original_packager": [true], "nui": ["N0000175713"], "pharm_class_epc": ["Antirheumatic Agent [EPC]"], "unii": ["G162GK9U4W"]}, "product_type": "Drugs", "event_id": "38329", "recalling_firm": "Apotex Corp.", "address_1": "2400 N Commerce Pkwy", "address_2": "Ste 400", "postal_code": "33326-3253", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "FAX", "distribution_pattern": "Nationwide.", "recall_number": "D-1662-2012", "product_description": "Leflunomide tablets, 20 mg, 1000-count bottle, Rx only, Manufactured for Apotex Corp., Weston, Florida 33326 by Apotex Inc., Toronto, Ontario Canada M9L 1T9, NDC 60505-2503-3", "product_quantity": "31", "reason_for_recall": "Subpotent (Single Ingredient Drug): Distribution of product that did not meet specifications.", "recall_initiation_date": "20070614", "center_classification_date": "20120827", "termination_date": "20120828", "report_date": "20120905", "code_info": "Lot #: GZ1274, Exp 11/07."}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076517"], "brand_name": ["CARBOPLATIN"], "generic_name": ["CARBOPLATIN"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["61703-339"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["CARBOPLATIN"], "rxcui": ["597195"], "spl_id": ["0ddf4411-7138-412a-908a-fadf22bdfb79"], "spl_set_id": ["c3ae9880-44bb-4f4e-93d8-8a5e21708a30"], "package_ndc": ["61703-339-18", "61703-339-22", "61703-339-50", "61703-339-56", "61703-360-50"], "is_original_packager": [true], "nui": ["N0000175413", "N0000175073"], "pharm_class_epc": ["Platinum-based Drug [EPC]"], "unii": ["BG3F62OND5"]}, "product_type": "Drugs", "event_id": "62459", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, including Puerto Rico and Guam.    Product was also distributed internationally to Australia, Belgium, Canada, France, Germany, Korea, Malaysia, New Zealand, Norway, Pakistan, Philippines, Portugal, Singapore, Sweden, Thailand and  Vietnam", "recall_number": "D-1679-2012", "product_description": "Carboplatin Injection, 10 mg/mL, 45 mL Multi-Dose Vial, Rx only,  antineoplastic/cytotoxic agent; Manufactured for Hospira, Inc., Lake Forest, IL 60045, Product of Australia, NDC 61703-339-50 (Hospira label), NDC 61703-360-50 (Novoplus label)", "product_quantity": "30,582 vials", "reason_for_recall": "The affected lots of Carboplatin Injection, Cytarabine  Injection, Methotrexate Injection, USP, and Paclitaxel Injection are beig recalled due to visible particles embedded in the glass located at the neck of the vial. There may be the potential for product to come into contact with the embedded particles and the particles may become dislodged into the solution.", "recall_initiation_date": "20120627", "center_classification_date": "20120919", "termination_date": "20161215", "report_date": "20120926", "code_info": "lot numbers Y061711AA, exp FEB 2013 and Y061711AB, exp FEB 2013    rest of world lots being recalled:   list M1685A001, lots numbers Y151686AB, exp MAY 2013 and Y131686AA, exp MAR 2013;   list M1723A001, lot number Y121686AF, exp SEP 2013;   list M1686ADE1, lot numbers Y121686AA, exp SEP 2013 and Y151686AC, exp NOV 2013;   list M1686AFR1, lot numbers Y121686AG, exp SEP 2013 and Y131686AB, exp SEP 2013;   list M1714A001, lot number Y121686AC, exp SEP 2013;   list M1686ANO3, lot number Y121686AE, exp SEP 2013;   list M1686ASE2, lot number Y121686AB, exp SEP 2013", "more_code_info": ""}, {"country": "United States", "city": "Roswell", "address_1": "1400 Holcomb Bridge Rd", "reason_for_recall": "Microbial Contamination of Non-Sterile Products; The affected lots were found to be contaminated with bacterium, Burkholderia cepacia complex.", "address_2": "", "product_quantity": "8994 Bottles", "code_info": "a) SKU 34136-00; Lot #: SA2137SLA, SA2136SLB, Exp 05/13,   SA2060SLB, Exp 02/14, SA2076SLB, SA2086SLC, SA2087SLA Exp 03/14, SA2131SLA, SA2135SLA, Exp 05/14  b) SKU 34135-00; Lot #: SA2086SLB, Exp 03/14  c) SKU 34111-00; Lot #: SA2086SLA, Exp 03/14, SA2122SLA, SA2123SLA, Exp 04/14", "center_classification_date": "20120712", "distribution_pattern": "Nationwide and Canada", "state": "GA", "product_description": "Kleenex Foam Hand Sanitizer, Alcohol Free in a) 1.5 fl oz. (45mL) , b) 8 fl oz. (236mL) , and c) 16 fl oz (473mL) bottles, Distributed by Kimberly Clark, LLC, Roswell, GA 30076", "report_date": "20120718", "classification": "Class II", "openfda": {}, "recalling_firm": "Kimberly-Clark Corporation", "recall_number": "D-1415-2012", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "62418", "termination_date": "20130409", "more_code_info": "", "recall_initiation_date": "20120614", "postal_code": "30076", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "42 units", "code_info": "Rx #'s: 0393353,  0393353,  0407779,  0368223,  0391077,  0395952,  0368516,  0369866,  0389267,  0369853,  0380629,  0395952,  0371048,  0366272,  0369842,  0369852,  0369854,  0369862,  0369864,  0369865,  0369868,  0369870,  0369874,  0397505,  0404200,  0398563,  0399971,  0400072,  0399080,  0371048,  0383814,  0387475,  0389061,  0399242,  0405935,  0402044,  0387322,  0380230", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "AMIKACIN P. F. 250MG/ML INJECTABLE 2 ML,4 ML; AMIKACIN SULFATE****  4ML SDV 250MG/ML INJECTABLE 40 ML; AMIKACIN SULFATE, LYOPHILIZED 4MG VIAL INJECTABLE 1 KIT,1 VIAL, 2 KIT, 2 KITS, 2 VIAL, 4 KIT, 4 VIAL; AMIKACIN SULFATE, LYOPHILIZED, OPHTHALMIC KIT 4MG VIAL INJECTABLE 1 KIT, 2 KIT, 4 KITS, 6 KIT; AMIKACIN SULFATE, OPHTHALMIC IN BSS, P.F. 4MG/ML INJECTABLE 0.1 ML, 0.2 ML, 2 ML, 2 MLS (18 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1454-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:  0386455", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "BUPIVACAINE/LIDOCAINE 0.11% / 0.44% INJECTABLE 150 ML (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1476-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62893", "recalling_firm": "VistaPharm, Inc.", "address_1": "7265 Ulmerton Rd", "address_2": "N/A", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1658-2012", "product_description": "Xactdose Phenytoin Oral Suspension, USP, 125mg/ 5 mL, supplied in 5 mL unit dose cups, Manufactured by VistaPharm, Inc., Largo, FL --- NDC 66689-035-50", "product_quantity": "N/A", "reason_for_recall": "Defective container; lidding deformity allows the contained product to transpire causing potential viscosity and assay failures. The viscosity and assay failures were due to the loss of moisture. The loss of moisture caused the viscosity to increase and assay to increase relative to the sample volume", "recall_initiation_date": "20110406", "center_classification_date": "20120821", "termination_date": "20121123", "report_date": "20120829", "code_info": "Lot 202800, NDC 66689-035-50"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "9 units", "code_info": "Rx #'s:  0359947      0408187    0359947    0389777        0389777", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "HYALURONIDASE / LIDOCAINE / BUPICAVAINE 7.1U/9.5MG/3.5MG/ML INJECTABLE 210 ML, 525 ML, 630 ML; HYALURONIDASE/LIDOCAINE/EPI/BUPIVICAINE  INJECTABLE 32 ML, 64 ML (5 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1536-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:     0379544", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "SESAME OPHTHALMIC  OIL\t60 ML  (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1617-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Chandler", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62779", "recalling_firm": "Island Kinetics dba Covalence", "address_1": "460 S Benson Ln Ste 3", "address_2": "N/A", "postal_code": "85224-5663", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Atlanta, Georgia", "recall_number": "D-1670-2012", "product_description": "CosMedix Serious Protection, Natural SPF 28 Sunscreen, 3.3 fl.oz/100mL (100 g), Distributed by CosMedix, LLC, Atlanta, GA --- Also labeled as RESULTS RX, Serious Protection Rx, SPF 28 Sunscreen, Net Wt. 4oz/120g.", "product_quantity": "5311 bottles", "reason_for_recall": "Microbial Contamination of Non Sterile Product; mold", "recall_initiation_date": "20120713", "center_classification_date": "20120829", "termination_date": "20130918", "report_date": "20120905", "code_info": "Batch # P030911C, Exp 03/13;  Batch # P022811A, Exp 02/13."}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "7 units", "code_info": "Rx #'s:  0406329    0374790    0399189          0399189", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "MEYERS COCKTAIL  INJECTABLE\t30 ML;  MEYERS COCKTAIL (DR. MORENO)  INJECTABLE\t90 ML;  MEYERS COCKTAIL/ CALCIUM/VIT B1/ METHYLCOBALAMIN 1GM/5MG/1000MCG/500ML  INJECTAB\t250 ML  \t  \t  \t  \t5 ML  (4 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1578-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Santa Fe Springs", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62756", "recalling_firm": "Capco Custom Packaging Inc", "address_1": "10225 Greenleaf Ave", "address_2": "N/A", "postal_code": "90670-3417", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Canada", "recall_number": "D-1664-2012", "product_description": "Eco-Dent Sparkling Clean Mint Ultimate Essential MouthCare, Natural Daily Rinse and Oral Wound Cleanser/Oral Debriding Agent, 8 fl oz (237 mL) bottle, Alcohol Free, Dist By: Eco Dent, 1100 Lakes Dr., Silver Lake, WI 53170 USA, UPC Code: 00037541", "product_quantity": "14380 Bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products; Product was found to be contaminated with Sphingomonas paucimobilis bacteria.", "recall_initiation_date": "20120727", "center_classification_date": "20120828", "termination_date": "20130328", "report_date": "20120905", "code_info": "Lot #: 4052, Exp 01/15; 4063, Exp 02/15; 4150, Exp 03/15."}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:   0387342", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "KENALOG-40** (MDV 10ML VIAL) 40MG/ML INJECTABLE\t50 ML  (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1551-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Shenandoah", "address_1": "604 W Thomas Ave", "reason_for_recall": "Subpotent (Single Ingredient Drug): Low assay at the 6-month test interval.", "address_2": "", "product_quantity": "19,039 bottles", "code_info": "LOT NO.1092045", "center_classification_date": "20120622", "distribution_pattern": "Nationwide", "state": "IA", "product_description": "Levothroid (levothyroxine sodium tablets, USP), 75 mcg., 100-count bottles, Rx only, NDC 0456-1322-01,   Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, Iowa 51601", "report_date": "20120704", "classification": "Class II", "openfda": {}, "recalling_firm": "Lloyd Inc", "recall_number": "D-1394-2012", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "61252", "termination_date": "20130730", "more_code_info": "", "recall_initiation_date": "20120224", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "12 units", "code_info": "Rx #'s:  0357028    0372461    0374296        0376008    0397681    0407302    0392293      0371718    0396669", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "FORMIX 100MCG / 30MG / 1MG  INJECTABLE 10 ML, 10 MLS, 5 ML; FORMIX 100MCG / 30MG / 2MG INJECTABLE 10 ML (4 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1522-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "El Paso", "address_1": "1550 Northwestern Dr", "reason_for_recall": "Lack of Assurance of Sterility: A customer complaint reported some units had incomplete seals (open seals) on the Individual unit packaging.", "address_2": "", "product_quantity": "67,775 Applicators", "code_info": "Product code 260415, Lot#: 48225", "center_classification_date": "20120917", "distribution_pattern": "Nationwide", "state": "TX", "product_description": "ChloraPrep with Tint, HI-Lite Orange, 3 mL Applicator, Patient Preoperative Skin Preparation, External Use Only, Sterile, product code 260415, Carefusion, Leawood, KS 66211, USA", "report_date": "20120926", "classification": "Class II", "openfda": {}, "recalling_firm": "Carefusion 213, Llc", "recall_number": "D-1674-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62971", "termination_date": "20130523", "more_code_info": "", "recall_initiation_date": "20111108", "postal_code": "79912-8000", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Lake Forest", "address_1": "275 N Field Dr", "reason_for_recall": "Superpotent; Cartridges labeled to contain 1 mL found to contain 2.2 mL", "address_2": "", "product_quantity": "212,370 cartidges", "code_info": "Lot #10830LL, Exp. 1APR2013", "center_classification_date": "20120715", "distribution_pattern": "Nationwide", "state": "IL", "product_description": "Morphine Sulfate Injection, USP,  4mg/mL, 1 mL fill in 2.5 mL Carpuject Cartridge Unit with Luer Lock, packaged 10 Carpujects/carton, CII, Rx only, Hospira, Inc., Lake Forest, IL  ---- NDC 0409-1258-30", "report_date": "20120725", "classification": "Class I", "openfda": {}, "recalling_firm": "Hospira Inc.", "recall_number": "D-1419-2012", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "61624", "termination_date": "20150529", "more_code_info": "", "recall_initiation_date": "20120417", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Weston", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA077954"], "brand_name": ["AZELASTINE HYDROCHLORIDE"], "generic_name": ["AZELASTINE HYDROCHLORIDE"], "manufacturer_name": ["Apotex Corp."], "product_ndc": ["60505-0833"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["NASAL"], "substance_name": ["AZELASTINE HYDROCHLORIDE"], "rxcui": ["1797867"], "spl_id": ["6ace9d74-df2e-8b53-9bc8-72a794f3a21a"], "spl_set_id": ["4f58c203-f649-a18e-aaf3-70b0797652f4"], "package_ndc": ["60505-0833-5"], "is_original_packager": [true], "unii": ["0L591QR10I"]}, "product_type": "Drugs", "event_id": "62930", "recalling_firm": "Apotex Corp.", "address_1": "2400 N Commerce Pkwy Ste 400", "address_2": "N/A", "postal_code": "33326-3253", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1667-2012", "product_description": "Azelastine HCl Nasal Solution, 0.1 %, 137 mcg/spray, 30 mL bottle (200 Metered Sprays), Rx only, Mfg by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, NDC 60505-0833-5.", "product_quantity": "963,407 bottles", "reason_for_recall": "CGMP Deviations: tubing used for filling may interact with the nasal formulation of this product.", "recall_initiation_date": "20110615", "center_classification_date": "20120829", "termination_date": "20120918", "report_date": "20120905", "code_info": "Lot #: JK9130, JM0925, Exp 05/12; JN6514, Exp 07/12; JN1125, JN1127, Exp 08/12; JR5780, JR5782, Exp 12/12."}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:    0382303", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "TROPICAMIDE OPHTHALMIC P.F. 1% SOLUTION\t30 ML  (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1632-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "6 units", "code_info": "Rx #'s:  0370786    0374590    0369109    0374590", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "SELENIUM 200MCG/ML INJECTABLE\t150 ML  \t30 ML  \t60 ML  (3 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1615-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "2 units", "code_info": "Rx #'s:  0408353    0404128", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "CEFAZOLIN IN ARTIFICIAL TEARS 50MG/ML OPHTHALMIC 10 ML; CEFAZOLIN VIAL*(25X1GM) 1GM INJECTABLE\t10 VIAL (2 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1481-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "15 units", "code_info": "Rx #'s:N0408787  N0390587  N0391850  N0397485  N0403240  N0387609  N0393487  N0393643  N0403803  N0388585  N0393489  N0401153  N0387605  N0405433  N0408195", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "BUPIVACAINE/HYDROMORPHONE, P.F. 15MG/40MG/ML INTRATHECAL 40 ML; BUPIVACAINE/HYDROMORPHONE, P.F. 22MG/30MG/ML INTRATHECAL 40 ML; BUPIVACAINE/HYDROMORPHONE, P.F. 7.5MG/20MG/ML INTRATHECAL 40 ML; BUPIVACAINE/HYDROMORPHONE, P.F. 7.5MG/25MG/ML INTRATHECAL 18 ML; BUPIVACAINE/HYDROMORPHONE, P.F. 7.5MG/50MG/ML INTRATHECAL 18 ML, 40 ML (6 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1475-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Monroe Township", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021358"], "brand_name": ["MULTIHANCE"], "generic_name": ["GADOBENATE DIMEGLUMINE"], "manufacturer_name": ["BRACCO DIAGNOSTICS INC"], "product_ndc": ["0270-5264"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["GADOBENATE DIMEGLUMINE"], "spl_id": ["42adc803-ceea-22aa-459c-f8617b2d8e56"], "spl_set_id": ["f63abe56-46d9-4e32-afb1-f4e22370717d"], "package_ndc": ["0270-5264-16", "0270-5264-17"], "is_original_packager": [true], "unii": ["3Q6PPC19PO"]}, "product_type": "Drugs", "event_id": "62735", "recalling_firm": "Bracco Diagnostics Inc", "address_1": "259 Prospect Plains Rd.", "address_2": "Building H", "postal_code": "08831", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1665-2012", "product_description": "Multihance Multipack (gadobenate dimeglumine) injection, 529 mg/mL, Pharmacy Bulk Package - Not for Direct Infusion, For Intravenous Use, Rx only,  a) 50 mL Single Dose Vial, b) 100 mL Single Dose Vial, Manufactured for: Bracco Diagnostics Inc. Princeton, NJ 08543 by Nycomed GmbH, 78224 Singen (Germany), NDC a) 0270-5264-16, b) 0270-5264-17.", "product_quantity": "4,870 Vials", "reason_for_recall": "Lack of Assurance of Sterility; Product recalled due to displacement of the aluminum crimp cap during product usage.", "recall_initiation_date": "20120416", "center_classification_date": "20120828", "termination_date": "20131113", "report_date": "20120905", "code_info": "Lot #: a) 9J37457, 9J44058, Exp 10/12; b) 9I28973, Exp 09/12"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62748", "recalling_firm": "American Health Packaging", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1668-2012", "product_description": "Mercaptopurine Tablets, USP, 50 mg, 30 Tablets (3 x 10) unit dose blisters per carton, Rx only, Packaged by American Health Packaging, 2550-A John Glenn Avenue, Columbus, OH  43217, barcode 6808432511; Carton labeling Dist by: Par Pharmaceutical Companies, Inc., Spring Valley, NY 10977, NDC 68084-325-21.", "product_quantity": "694 cartons", "reason_for_recall": "Failed USP Dissolution Test Requirements: This sub-recall is in response to Prometheus Laboratories Inc. recall for Mercaptopurine USP 50mg because the lot does not meet the specification for dissolution.", "recall_initiation_date": "20120723", "center_classification_date": "20120829", "termination_date": "20130219", "report_date": "20120905", "code_info": "Lot #: 120604 Exp 2/28/2013"}, {"country": "United States", "city": "Sanford", "address_1": "2650 S Mellonville Ave", "reason_for_recall": "Subpotent; fluocinolone acetonide", "address_2": "", "product_quantity": "111,816 bottles", "code_info": "Lot Numbers:   -Body Oil: J100095 (exp 09/12), J100099 (exp 09/12), K100106 (exp 10/12), K100111 (exp 10/12), L100872 (exp 11/12), L100880 (exp 11/12), D110560 (exp 04/13).", "center_classification_date": "20120814", "distribution_pattern": "Nationwide", "state": "FL", "product_description": "Derma-Smoothe/FS (Fluocinolone Acetonide) 0.01%, Body Oil, 4 fl. oz. (118.28mL ), Rx only, FOR TOPICAL USE ONLY, Manufactured and Distributed by: Hill Dermaceuticals, Inc. SANFORD, FLORIDA --- NDC 28105-150-04", "report_date": "20120822", "classification": "Class III", "openfda": {}, "recalling_firm": "Hill Dermaceuticals, Inc.", "recall_number": "D-1647-2012", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "62607", "termination_date": "20150210", "more_code_info": "", "recall_initiation_date": "20120508", "postal_code": "32773-9311", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Fort Worth", "state": "TX", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "62803", "recalling_firm": "Galderma Laboratories, L.P.", "address_1": "14501 N Freeway Tx", "address_2": "N/A", "postal_code": "76177", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico.", "recall_number": "D-1660-2012", "product_description": "Capex Shampoo (fluocinolone acetonide), Topical Shampoo, 0.01%, Rx only, For Topical Use Only, 4 fl oz in a 6 oz bottle, Marketed by: Galderma Laboratories, LP, Fort Worth, TX, Mfd. by: Hill Dermaceuticals, Inc., Sanford, FL --- NDC 0299-5500-04,", "product_quantity": "17,160 bottles", "reason_for_recall": "Subpotent; fluocinolone acetonide.", "recall_initiation_date": "20120815", "center_classification_date": "20120824", "termination_date": "20130222", "report_date": "20120905", "code_info": "Lots J090181-H100089, J090181-J100096, and J090181-K100102."}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA074880"], "brand_name": ["ALBUTEROL SULFATE"], "generic_name": ["ALBUTEROL SULFATE"], "manufacturer_name": ["Nephron Pharmaceuticals Corporation"], "product_ndc": ["0487-9501"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["ALBUTEROL SULFATE"], "rxcui": ["630208"], "spl_id": ["326308f5-f46e-3467-e063-6394a90a7752"], "spl_set_id": ["574824f3-51cc-4b94-9c10-e3204d8b19f8"], "package_ndc": ["0487-9501-25", "0487-9501-03", "0487-9501-60", "0487-9501-01"], "is_original_packager": [true], "upc": ["0304879501003"], "unii": ["021SEF3731"]}, "product_type": "Drugs", "event_id": "62604", "recalling_firm": "Nephron Pharmaceuticals Corp.", "address_1": "4121 SW 34th St", "address_2": "", "postal_code": "32811-6475", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1446-2012", "product_description": "Albuterol Sulfate Inhalation Solution, 0.083%, 2.5 mg/3 mL Sterile Unit-Dose Vials, 60-count (60 x 3 mL Sterile Unit-Dose Vials) per carton, Rx only, Manufactured by: nephron pharmaceuticals corporation, Orlando, FL  32811, NDC 0487-9501-60.", "product_quantity": "56,028 cartons", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20110622", "center_classification_date": "20120809", "termination_date": "20121115", "report_date": "20120815", "code_info": "Lot #: A0654A, Exp 07/12; A0A62A, Exp 10/12", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #: 0390157", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "AMINOPHYLLINE 20ML, SDV** 500MG (25MG/ML) INJECTABLE 20 ML (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1455-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "7 units", "code_info": "Rx #'s:N0391871  N0395248  N0400014  N0404731  N0404936  N0408940  N0387888", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "HYDROMORPHONE/BACLOFEN/BUPIVACAINE (0.9% NACL) 50MG/1000MCG/7.5MG/ML INTRATHECAL 18 ML; HYDROMORPHONE/BACLOFEN/BUPIVACAINE (0.9% NACL) 50MG/1500MCG/7.5MG/ML INTRATHECAL 18 ML;  HYDROMORPHONE/BACLOFEN/BUPIVACAINE (0.9% SODIUM CHLORIDE) 50MG/500MCG/7.5MG/ML I 18 ML (3 DIFFEENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1541-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62605", "recalling_firm": "Zydus Pharmaceuticals USA Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1428-2012", "product_description": "Metformin Hydrochloride Tablets, USP, 1000 mg, Rx only, 1000 count tablets per Bottle,  Manufactured by: Cadila Healthcare LTD. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534, NDC 68382-030-10.", "product_quantity": "1176 Bottles", "reason_for_recall": "Presence of Foreign Substance(s): A product complaint was received from a pharmacist who discovered that several tablets displayed brown specks.  The same complainant also reported that metal shaving like material was observed on the surface of one tablet.", "recall_initiation_date": "20120314", "center_classification_date": "20120727", "termination_date": "20131217", "report_date": "20120808", "code_info": "Lot #: ML9605 Exp. 10/2013"}, {"country": "United States", "city": "Telford", "address_1": "306 Keystone Dr", "reason_for_recall": "Labeling; labeled with incorrect EXP Date; Incorrect expiration date printed on the outer packaging.  Package incorrectly states 5/2014 should correctly state 4/2014", "address_2": "Unit B", "product_quantity": "13,128 bottles", "code_info": "Lot D12044, Exp 4/2014,  NDC 0904-5255-30", "center_classification_date": "20120802", "distribution_pattern": "Michigan", "state": "PA", "product_description": "Major brand Infants' Mapap, Acetaminophen Concentrated Drops, 1 FL. OZ. (30 mL.) 80 mg. per 0.8 mL, Cherry Flavor, Distributed by MAJOR PHARMACEUTICALS, Livonia, MI --- NDC 0904-5255-30,", "report_date": "20120808", "classification": "Class III", "openfda": {}, "recalling_firm": "Axcentria Pharmaceuticals LLC", "recall_number": "D-1441-2012", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "62628", "termination_date": "20130716", "recall_initiation_date": "20120712", "postal_code": "18969", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "2 units", "code_info": "Rx #'s:   0397185    0408097", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "EDETATE DISODIUM PF IN BSS 3% OPHTHALMIC 10 ML; EDETATE DISODIUM SOLUTION IN ARTIFICIAL TEARS 0.05% OPHTHALMIC 10 ML (2 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1511-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "14 units", "code_info": "Rx #'s:  0407225    0407852      0405175    0408193    0403243    0404737    0392573    0392575    0392577    0392575    0401951      0404831", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "KETOROLAC TROMETHAMINE 30MG/ML INJECTABLE\t10 ML  \t  \t  \t24 ML  \t  \t500 ML;  KETOROLAC TROMETHAMINE 60MG/ML INJECTABLE\t48 ML;  KETOROLAC TROMETHAMINE, 1ML SDV**25X1ML 30MG/ML INJECTABLE\t50 ML  \t  \t  \t75 ML;  KETOROLAC TROMETHAMINE, P.F. 60MG/ML INJECTABLE\t10 ML  (7 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1552-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "160 units", "code_info": "Rx #'s:   C0371167  C0371185  C0371187  C0371193  C0381331  C0381336  C0381348  C0381353  C0381360  C0381364  C0381366    C0381371  C0384632  C0384634  C0384637  C0389199  C0389200  C0389201  C0389205  C0389216  C0389219  C0389223  C0389224  C0392398  C0392399  C0392401  C0392405    C0392407    C0392409    C0392410  C0392411    C0392412    C0392414    C0392418  C0392419    C0392421  C0392426  C0392429  C0392433    C0392434    C0392435    C0392436    C0392438  C0392441    C0394169  C0394170  C0394171  C0394172  C0394173  C0394174  C0394175  C0394176  C0394177  C0394178  C0394179  C0394180  C0396357  C0396362  C0396365  C0396370  C0396374  C0396377  C0396388  C0396397  C0396398  C0397477  C0397478  C0397479  C0397481  C0397482  C0397484  C0397486  C0397487  C0397488  C0397489  C0397491  C0397492  C0397493  C0397494  C0397495  C0397496  C0397497  C0397498  C0397500  C0397501  C0397502  C0400024  C0400033  C0400034  C0400035  C0400036  C0400037  C0400038  C0400039  C0400040  C0400041  C0400218  C0400219  C0400221  C0400223  C0400224  C0400225  C0400226  C0400230  C0400231  C0400232  C0400233  C0400236  C0400237  C0400238  C0400239  C0400240  C0400242  C0400243  C0402690  C0402700  C0402701  C0402704  C0402705  C0402708  C0402717  C0402719  C0402721  C0402723  C0402724  C0402727  C0402731  C0402734  C0406972  C0371720  C0395592      C0405074  C0405076  C0405101  C0405103  C0405108  C0405114  C0407649  C0407651  C0407653  C0407654  C0391968  C0403337  C0401434  C0401434", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "NANDROLONE DECANOATE (H) 200MG/ML INJECTABLE\t1 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t5 ML  \t  \t  \t  \t6 ML;  \t  \t  \t  \t  \t  \t  \t  \t  \t  NANDROLONE DECANOATE 100MG/ML INJECTABLE\t5 ML;  \t  NANDROLONE DECANOATE 300MG/ML INJECTABLE\t10 ML  \t30 ML  (6 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1588-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Chino", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "62442", "recalling_firm": "Health Plus Incorporated", "address_1": "13837 Magnolia Ave", "address_2": "N/A", "postal_code": "91710", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1406-2012", "product_description": "Super Colon Cleanse, stimulant laxative, 140 mg of Senna per capsule, 25 doses, 100 capsules, Manufactured by: healthPLUS Inc. Chino, CA 91710 USA.", "product_quantity": "24,423 bottles", "reason_for_recall": "Labeling: Label Mix-up:  The product is being recalled because active ingredient in the Drug Facts box incorrectly states &quot;Active Ingredients per dose&quot; Senna Leaf powder 140 mg.  It should correctly be stated as &quot;Active ingredient (in each capsule)&quot; Senna Leaf Powder 140 mg.It should correctly be stated as Active ingredient (in each capsule)  Senna Leaf Powder 140 mg.", "recall_initiation_date": "20120628", "center_classification_date": "20120703", "termination_date": "20130115", "report_date": "20120711", "code_info": "Lot number 120502276, Expiration date 05/2015, UPC Code 08807/11/0 -- revision number 08807/11/0.    Lot number 120201286, Expiration date 03/2015, UPC Code 08807/11/0."}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "2 units", "code_info": "Rx #'s:   0386748    0389778", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "LABETALOL HYDROCHLORIDE 5MG/ML INJECTABLE\t100 ML  \t80 ML  (2 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1553-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Hobart", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "61967", "recalling_firm": "Mallinckrodt Inc.", "address_1": "172 Railroad Avenue", "address_2": "N/A", "postal_code": "13788-0416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1431-2012", "product_description": "Hydrocodone Bitartrate and Acetaminophen Oral Solution, 7.5 mg/500 mg per 15 mL, 16 fl oz (473 mL) bottle, Rx only, Mallinckrodt Inc., Hazelwood, MO 63042 USA, NDC 0406-0375-16, UPC 3 0406-0375-16 1.", "product_quantity": "44,330 bottles", "reason_for_recall": "CGMP Deviations: This product is being recalled because expired flavoring was used in the manufacturing of these lots.", "recall_initiation_date": "20120525", "center_classification_date": "20120731", "termination_date": "20150417", "report_date": "20120808", "code_info": "Lot #: 0375P76192, Exp 07/12; 0375T80512, Exp 08/13; 0375T81209, Exp 09/13"}, {"country": "United States", "city": "Ridgeland", "address_1": "103 W. Washington Street", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Samples tested by FDA were found to contain sulfoaildenafil, an analogue of sildenafil, an FDA approved drug used in the treatment of male erectile dysfunction, making these products unapproved new drugs.", "address_2": "Suite B5", "product_quantity": "585,000 Capsules", "code_info": "Lot #s: a) 101108, 101009, 101010, 101011; b) 101108, 101109, 101110; c) 301000, 301001", "center_classification_date": "20120820", "distribution_pattern": "Nationwide", "state": "MS", "product_description": "V Maxx Rx, All Natural Male Enhancement, a) 1-count blister pack UPC Code 2802803561; b) 5-count blister pack UPC Code 0972859402; c) 10-count bottle UPC code 0913251017 bottles, Manufactured by The Menz Club, LLC, 103 W. Washington Street, Suite B5, Ridgeland, MS  39157, Phone: 601-866-6746", "report_date": "20120829", "classification": "Class I", "openfda": {}, "recalling_firm": "The Menz Club, LLC", "recall_number": "D-1657-2012", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "61957", "termination_date": "20151207", "recall_initiation_date": "20120525", "postal_code": "39157", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "171 units", "code_info": "Rx #'s:  0402163    0401103    0361246    0374339    0400819    0401878    0376767    0357627      0358558    0385752    0387435                0388683    0398782          0389025    0389135    0394537    0400051    0410208    0389025                0388231    0391057      0405031    0393211    0393211    0388792      0384288            0407535    0378398    0378398          0377517        0378503    0378504    0380549      0381687    0383319    0385206      0390165    0390166    0390930    0392241    0396501      0396675    0397835    0398312    0398392      0398889    0402538    0402842    0405320    0408916    0378060            0378502    0385165              0399334    0399337    0399340    0399345    0399348    0408326    0405172    0396619    0393974    0378077    0380549    0385218      0399333    0399346    0399349    0399351    0399353    0399354    0399356    0399358    0399361    0399362    0392241    0405640    0402538    0396501    0377276    0377517    0377857    0378077    0379493    0380295    0380549    0380551    0381687    0385218    0387271    0387274    0387280    0387282    0389068    0390166    0390930    0391460    0391463    0391466    0391469    0391576        0391881    0392180      0392182      0392184      0395103      0395519    0396501      0404869    0409343    0409489    0409490    0409492    0410150    0410384    0367933    0395652      0396783        0408328    0402535", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "GENTAMICIN  40MG/ML (80MG/2ML) INJECTABLE 20 ML, 40 ML, 48 ML, 50 ML;  GENTAMICIN / SODIUM BICARBONATE (STERILE) 480MG/LITER SOLUTION 1000 ML; GENTAMICIN /CLINDAMYCIN /POLYMIXIN B/STERILE WATER  0.1%/0.1%/0.05% SOLUTION 250 ML, 500 ML; GENTAMICIN DROPS (FORTIFIED) 14MG/ML (1.4%) OPHTHALMIC 10 ML; GENTAMICIN DROPS (FORTIFIED) 15MG/ML (1.5%) OPHTHALMIC 10 ML, 15 ML; GENTAMICIN DROPS (FORTIFIED) 18MG/ML (1.8%) OPHTHALMIC 5 ML; GENTAMICIN IRRIGATION 1GM/LITER SOLUTION 2000 ML; GENTAMICIN IRRIGATION 480MG/LITER SOLUTION 1000 ML, 2000 ML; GENTAMICIN***(80MGX2ML) 40MG/ML INJECTABLE\t100 ML, 100 MLS, 100 VIAL, 12 ML, 14 ML, 150 ML, 200 ML, 25, 40 ML, 50 ML, 50 MLS, 50 VIALS (26 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1528-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Broomfield", "address_1": "2555 W Midway Blvd", "reason_for_recall": "Impurities/Degradation Products: An out of specification result for a known impurity of the product occurred during 12 month stability testing.", "address_2": "", "product_quantity": "41,761bottles.", "code_info": "Lot numbers: KW10J511, KW10J512, KW10J513, KW10J514, KW10J515, BJ3167, BJ3172, BJ3177, BJ3179, BJ3188, BJ3182. Exp. 09/12", "center_classification_date": "20120919", "distribution_pattern": "Nationwide", "state": "CO", "product_description": "Pramipexole Dihydrochloride Tablets, 0.125 mg, 90-count tablets per bottle, Rx only, Manufactured in India by Sandoz Private Ltd., for Sandoz Inc., Princeton, NJ 08540, NDC 0781-5248-92", "report_date": "20120926", "classification": "Class III", "openfda": {}, "recalling_firm": "Sandoz Incorporated", "recall_number": "D-1678-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "63160", "termination_date": "20130410", "more_code_info": "", "recall_initiation_date": "20120912", "postal_code": "80020-1632", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "15 units", "code_info": "Rx #'s:  0397942              0397942    0395256    0395256    0387634        0397219    0400108    0387634    0370170    0370170            0370170    0389690        0389690", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "LIDOCAINE HCL/EPINEPHRINE IN BSS - P.F., SULFITE-FREE 0.75%/0.025% INJECTABLE\t24 ML  \t  \t  \t  \t  \t  \t6 ML;  LIDOCAINE HCL/EPINEPHRINE, P.F., SULFITE-FREE 2%/1:100,000 (0.001%) INJECTABLE\t10 ML  \t40 ML;  LIDOCAINE HCL/EPINEPHRINE. 2%/1:100,000 (0.001%) INJECTABLE\t100 ML  \t  \t  \t1200 ML  \t300 ML  \t80 ML;  LIDOCAINE/EPINEPHRINE  1%/0.00025% OPHTHALMIC\t30 ML  \t60 ML  \t  \t  \t  \t  \t90 ML;  LIDOCAINE/EPINEPHRINE, P.F. (FOR DILUTION WITH BSS+) 1.71%/0.057% OPHTHALMIC\t14 ML  \t  \t  \t7 ML  (8 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1560-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "4 units", "code_info": "Rx #'s:  0405776    0405779    0393390    0405545", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "GLYCERIN   99.5% OPHTHALMIC 10 ML, 5 ML, 7.5 ML; GLYCERIN  100% OPHTHALMIC 15 ML (4 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1530-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "188 units", "code_info": "Rx #'s:  0406657    0405526    0391965    0393529    0390040    0362442      0370756    0378145    0386548    0393611    0394410    0394751    0394753    0395981      0397434    0398818    0399650    0399825    0399848    0399854    0400112    0401949    0404137    0404138    0404295    0405528    0405700    0407504    0407507    0407770    0408225    0408229    0408670    0410088    0370756      0376063    0391443    0397137        0397222      0397227    0402055    0406817    0391443    0362442      0375777          0390216        0392072    0392079    0392091      0395270    0395277    0395284    0398284    0400112    0403421    0370756                  0391443      0362395    0374541    0375777        0395538    0407969    0391443    0374541      0376063    0395987    0395989    0397137    0402055    0387769    0370756    0374541    0376063    0374541    0383057    0385833    0387137    0387361      0387564    0387810    0388478    0390588        0391303    0392314    0392586      0393046    0393339    0394113    0394120    0395617      0395663    0395677    0396139    0397002    0397162    0397275    0397424    0397438    0397462    0397528    0397934    0398287    0398574    0398695    0398774    0399172    0399416    0399658    0399659    0399766      0399862    0400268    0400583    0400688      0400834    0401416    0401429    0401445    0401476    0401499    0401683    0401771    0402350    0403007    0403151      0403488    0403593    0403594    0403874      0404051    0404293    0404566    0404649    0404671    0404837    0404856    0404868    0404916    0405436    0405907    0405938    0406152    0406239    0406886    0407034    0407563    0408732    0381970    0388666    0402009    0376106        0393514    0405150", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "MIC - COMBO WITH METHYLCOBALAMIN 0.8/1.6/1.6/0.0001/0.03% INJECTABLE\t10 ML  \t150 ML  \t30 ML;  \t  MIC COMBO + CHORIONIC GONADOTROPIN + B12 500U/40MCG/ML (125U/10MCG/0.25ML) INJEC\t6 ML;  MIC COMBO + CHORIONIC GONADOTROPIN, LYOPHILIZED 10,000 UNIT VIAL INJECTABLE\t1 VIAL  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t10 VIAL  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t15 VIAL  \t2 VIAL  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t20 VIAL  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t4 VIAL  \t  \t  \t  \t  \t  \t  \t40 VIAL  \t5 VIAL  \t  \t  \t  \t  \t  \t  \t50 VIAL  \t6 VIAL  \t  \t7 VIAL  \t8 VIAL  MIC COMBO + CHORIONIC GONADOTROPIN, LYOPHILIZED(KIT) 10,000 UNIT VIAL INJECTABLE\t1 KIT  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t2 KIT  \t  \t  \t4 KIT  \t  \t  MIC COMBO + CHORIONIC GONADOTROPIN, LYOPHILIZED(KIT) II 10,000 UNIT VIAL INJECTA\t1 KIT  (20 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1579-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "6 units", "code_info": "Rx #'s:  0394909    0394909    0394909    0394909      0394909", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "TROPICAMIDE/PHENYLEPHRINE  OPHTHALMIC 15:1 SOLUTION\t128 ML  \t480 ML  \t496 ML  \t576 ML  \t  \t90 ML  (5 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1633-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:  0403172", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "ETOMIDATE  0.2% (2MG/ML) INJECTABLE 20 ML (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1517-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}]